← Back to catalogue

TEVADAPTOR® Secondary IV Administration Set with ULTRASITE® Inj. Site

FDA UDI

Class II (US FDA UDI)

by Teva Pharmaceutical Industries Limited

Identity

Trade Name
TEVADAPTOR® Secondary IV Administration Set with ULTRASITE® Inj. Site FDA UDI
Generic Name
Basic intravenous administration set, noninvasive FDA UDI
Device Name
TEVADAPTOR® Secondary IV Administration Set with ULTRASITE® Injection Site for use with OnGuardTM contained Medication System FDA UDI
Model / Reference
MG412120 FDA UDI
Description
TEVADAPTOR® Secondary IV Administration Set with ULTRASITE® Injection Site for use with OnGuardTM contained Medication System FDA UDI

Identifiers

Catalog Number
MG412120 FDA UDI
Primary DI / UDI-DI
27298119121205 FDA UDI
510(k) Number
K121269 FDA UDI
FDA Product Code
FPA FDA UDI
GMDN Term
Basic intravenous administration set, noninvasive FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
880.5440 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

Yes

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Basic intravenous administration set, noninvasive

TEVADAPTOR® Secondary IV Administration Set with ULTRASITE® Inj. Site by Teva Pharmaceutical Industries Limited — Class II — FDA UDI — listed in FDA GUDID

Similar devices

Also classified as Basic intravenous administration set, noninvasive.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 1080b927-217c-484c-9367-54502bfd252d 35 fields · synced May 31, 2026